Bain Capital and 11North Partners paid $395 million for a portfolio of 10 shopping centers in Florida and South Carolina, ...

Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets.

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Bob's Discount Furniture could be valued at ~$1B if the retailer were to command a multiple of around five-times EBITDA, ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain's $300 million financing round, the ...

Bain Capital Specialty Finance, Inc. (BCSF) Q2 2025 Management View CEO Michael Alexander Ewald highlighted "Q2 net investment income per share was $0.47, representing an annualized yield on book ...

Pharma is looking for fewer, scaled providers at an enterprise level to reduce risk and provide a better-integrated service,' ...

Bain Capital co-chairman Steve Pagliuca is retiring after a 34-year career at the private-equity firm. Mr. Pagliuca will remain a senior adviser at the firm, and will continue to be involved in ...

Athenahealth’s $17 billion takeover is the latest private equity megadeal. Hellman & Friedman and Bain Capital are taking over the health care software company. By Michael J. de la Merced Nov ...

Bain Capital LP raised $7.1 billion for its new buyout fund dedicated to Asia-Pacific, people familiar with the matter said, defying a fundraising gloom triggered by lingering economic concerns ...

Bain Capital Ventures is doubling down on what works, literally. The venture firm, one of Bain’s 11 financial divisions, has raised $1.9 billion across two funds, one for seed to growth-stage ...

At Bain, a broad range of viewpoints is the new reality By Beth Healy and Matt Rocheleau Globe Staff,April 16, 2015, 12:00 a.m.